Would It Be A Good Move Today To Buy Clover Health Investments Corp. (CLOV) Stock?

As of Thursday close, Clover Health Investments Corp.’s (NASDAQ:CLOV) stock was up $0.16, moving up 7.51 percent to $2.29. The average number of shares traded per day over the past five days has been 15,563,180 shares. 2 times new highs have been achieved over the past 5 days, with a -$0.54 fall in that time frame. In the last twenty days, the average volume was 8,441,195, while in the previous 50 days, it was 11,375,762.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Since last month, CLOV stock retreated -25.16%. Shares of the company fell to $1.99 on 05/12/22, the lowest level in the past month. A 52-week high of $28.85 was reached on 01/03/22 after having rallying from a 52-week low of $1.95. Since the beginning of this year, CLOV’s stock price has dropped by -38.44% or -$1.43, and marked a new high 1 time. However, the stock has declined by -92.06% since its 52-week high.

Clover Health Investments Corp. (CLOV) last reported insider trading activity 63 days ago on Mar 11. SHAPIRO LEE, the Director of the company, purchased of 80,000 shares for $3.10 on Mar 11. It resulted in a $248,072 investment by the insider. Clinton Chelsea added 100,000 shares at an average price of $2.53 on Mar 03. The insider now owns 100,000 shares following the transaction. On Nov 22, 10% Owner Palihapitiya Chamath bought 1,739,130 shares at $5.75 apiece. The transaction was valued at $9,999,998.

Financial Health

In the three months ended September 29, Clover Health Investments Corp.’s quick ratio stood at 2.00, while its current ratio was 2.00, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.04. In the year ended September 29, operating margins totaled -43.30%. Based on annual data, CLOV earned -$71.55 million in gross profit and brought in $1.47 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -114.70%. Return on equity (ROE) for the past 12 months was -127.80%.

In Clover Health Investments Corp.’s quarter-end financial report for September 29, it reported total debt of $19.95 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. CLOV’s revenue rose 77.09% to $432.04 million during the quarter, while net income inched up to $874.38 million. While analysts expected Clover Health Investments Corp. to report -$0.23 quarterly earnings, the actual figure was -$0.08 per share, beating the consensus estimate by 65.20%. During the quarter, the company generated -$86.49 million in EBITDA. The liabilities of Clover Health Investments Corp. were 2.19 billion at the end of its most recent quarter ended September 29, and its total debt was $28.48 million. The value of shareholders’ equity is $473.36 million.

Technical Picture

This quick technical analysis looks at Clover Health Investments Corp.’s (CLOV) price momentum. With a historical volatility rate of 98.05%, the RSI 9-day stood at 32.95% on 12 May.

With respect to its five-day moving average, the current Clover Health Investments Corp. price is down by -19.08% percent or -$0.54. At present, CLOV shares trade -27.30% below its 20-day simple moving average and -45.35% percent below its 100-day simple moving average. However, the stock is currently trading approximately -14.23% below its SMA50 and -72.48% below its SMA200.

Stochastic coefficient K was 14.09% and Stochastic coefficient D was 18.81%, while ATR was 0.28. Given the Stochastic reading of 31.58% for the 14-day period, the RSI (14) reading has been calculated as 35.49%. As of today, the MACD Oscillator reading stands at -0.32, while the 14-day reading stands at -0.37.

Analyst Ratings

Cowen upgraded its rating on Clover Health Investments Corp. (NASDAQ: CLOV) to a Market perform in a note to investors on February 02, 2022. The analysts firm previously had an Underperform rating on the stock.Clover Health Investments Corp. (CLOV) has been rated Hold by analysts. According to 1 brokerage firm, CLOV is a sell, and 3 firms recommend it is a Hold. There are 1 analyst who say the stock is underweight. A total of 0 analysts rate Clover Health Investments Corp. stock as buy, with 1 recommending it as overweight.

With a median target price of $3.25, the current consensus forecast for the stock is $3.00 – $7.00. Based on these forecasts, analysts predict Clover Health Investments Corp. (CLOV) will achieve an average price target of $4.00.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles